A federal judge rejected the government's argument that insurers shouldn't be grouped together in the suit over cost-sharing reduction payments because their alleged damages would vary.
Highmark Health, a Pittsburgh-based Blues plan, has reached a value-based drug-pricing contract with AstraZeneca for Symbicort, which is used to treat asthma and other chronic lung diseases.
A federal judge blocked the proposed $54 billion tie-up between national insurers Anthem and Cigna late Wednesday, saying the combination would harm competition in the national employer market.
As the Trump administration and some in Congress whittle away at the Affordable Care Act, blue states are filling in gaps in an attempt to bolster their markets. Others are picking up chainsaws.
Gov. Scott Walker said the $200 million reinsurance program would lower premiums by 5% in 2019, a dramatic shift after they increased 44% this year as enrollment dropped and fewer providers offered coverage.
Two top Senate Democrats say the Trump administration is raising more questions than it is answering by changing course on funding risk-corridor payments.